Unknown

Dataset Information

0

The stress of coping with E2F loss.


ABSTRACT: E2F transcription factors are key regulators of cellular proliferation, and altered E2F activity is a common feature of tumor cells. Thus, E2F targeting is being explored as a therapeutic strategy in cancer. Importantly, recent mouse knockout studies show that concomitant loss of E2f1/E2f2 activity is associated with increased genomic instability and oncogenic potential in normal differentiating cells, a finding that might have implications for cancer therapy.

SUBMITTER: Iglesias-Ara A 

PROVIDER: S-EPMC4845195 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8346057 | biostudies-literature
| S-EPMC5647247 | biostudies-literature
2016-09-30 | GSE87490 | GEO
| S-EPMC6151040 | biostudies-literature
| S-EPMC4698175 | biostudies-literature
| S-EPMC6549991 | biostudies-literature
| S-EPMC6258784 | biostudies-other
| S-EPMC10061830 | biostudies-literature
| S-EPMC2930418 | biostudies-literature
| S-EPMC4978278 | biostudies-literature